Open AccessCutaneous Pigmentation After Photosensitivity Induced by Vandetanib Therapy
Author(s) -
Heidi H. Kong,
Howard A. Fine,
Jere B. Stern,
Maria L. Turner
Publication year - 2009
Publication title -
archives of dermatology
Language(s) - English
Resource type - Journals
eISSN - 1538-3652
pISSN - 0003-987X
DOI - 10.1001/archdermatol.2009.177
Subject(s) - vandetanib , photosensitivity , hyperpigmentation , medicine , dermatology , tyrosine kinase , receptor , physics , quantum mechanics
Photosensitivity has been reported in patients who were treated with vandetanib (ZD6474), an inhibitor of epidermal growth factor receptor, vascular endothelial growth factor receptor, and the RET (rearranged during transfection) kinases.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom